Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionChecchi Capital Advisers, LLC
Latest Disclosed Ownership1,570 shares
Latest Disclosed Value $ 701,068
Checchi Capital Advisers, LLC reports 13.36% increase in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On May 4, 2026 - Checchi Capital Advisers, LLC filed a 13F-HR form disclosing ownership of 1,570 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $701,068 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 27, 2026 disclosing 1,385 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 13.36% during the quarter. The current value of the position is $701,523 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-04 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,570 185 13.36 701 11.80 0.0354
2026-01-27 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,385 -76 -5.20 628 9.62 0.0321
2025-11-05 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,461 -333 -18.56 572 -28.32 0.0297
2025-07-22 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,794 -41 -2.23 799 -10.24 0.0447
2025-04-29 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,835 31 1.72 890 22.45 0.0469
2025-02-05 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,804 -13 -0.72 726 -14.08 0.0423
2024-11-04 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,817 12 0.66 845 -0.12 0.0472
2024-07-26 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,805 118 6.99 846 20.00 0.0424
2024-04-25 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,687 24 1.44 705 4.29 0.0551
2024-02-07 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,663 22 1.34 677 18.60 0.0549
2023-11-13 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,641 -553 -25.21 571 -26.17 0.0529
2023-08-10 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 2,194 485 28.38 772 43.49 0.0690
2023-05-08 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,709 10 0.59 538 9.80 0.0520
2023-02-10 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,699 116 7.33 491 6.99 0.0510
2022-11-09 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,583 23 1.47 458 4.81 0.0428
2022-08-11 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,560 130 9.09 437 17.16 0.0378
2022-05-09 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,430 297 26.21 373 49.80 0.0317
2022-02-09 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,133 -103 -8.33 249 11.16 0.0219
2021-11-09 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,236 -82 -6.22 224 -15.79 0.0222
2021-08-06 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,318 -81 -5.79 266 -11.63 0.0262
2021-05-10 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,399 -88 -5.92 301 -14.25 0.0298
2021-02-12 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,487 -222 -12.99 351 -24.52 0.0362
2020-11-10 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,709 103 6.41 465 -0.21 0.0516
2020-08-12 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,606 208 14.88 466 39.94 0.0557
2020-05-07 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,398 -69 -4.70 333 3.74 0.0319
2020-02-07 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,467 8 0.55 321 29.96 0.0430
2019-11-06 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,459 48 3.40 247 -4.63 0.0321
2019-08-06 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,411 231 19.58 259 19.35 0.0329
2019-05-09 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,180 -59 -4.76 217 5.85 0.0254
2019-02-07 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,239 -360 -22.51 205 -33.44 0.0265
2018-10-29 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,599 39 2.50 308 16.23 0.0355
2018-08-06 2018-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,560 144 10.17 265 14.72 0.0333
2018-05-01 2018-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,416 78 5.83 231 14.93 0.0304
2018-02-02 2017-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,338 1,338 201 0.0270
2016-11-10 2016-09-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 0 -1,763 -100.00 0 -100.00
2016-07-21 2016-06-30 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,763 73 4.32 152 13.43 0.0174
2016-05-02 2016-03-31 13F VERTEX PHARMACEUTICALS INC COM Stock 92532F100 1,690 -291 -14.69 134 -46.18 0.0298
2016-02-03 2015-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,981 1,981 0.00 249 0.0628
2015-10-23 2015-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -1,629 -100.00 0 -100.00
2015-08-04 2015-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,629 1,629 201 0.0530
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.